Wei Shen Lim
#98,569
Most Influential Person Now
Respiratory physician in England
Wei Shen Lim's AcademicInfluence.com Rankings
Wei Shen Limphilosophy Degrees
Philosophy
#4838
World Rank
#7495
Historical Rank
Logic
#2213
World Rank
#3157
Historical Rank
Download Badge
Philosophy
Wei Shen Lim's Degrees
- PhD Respiratory Medicine University of Oxford
Why Is Wei Shen Lim Influential?
(Suggest an Edit or Addition)According to Wikipedia, Wei Shen Lim is a consultant respiratory physician and honorary professor of medicine at Nottingham University Hospitals NHS Trust, England. Lim graduated from University of Nottingham Medical School in 1991 and has been on the specialist register for General Internal Medicine and Respiratory Medicine since 2002. Since November 2020 or earlier, he has been chairman of the COVID-19 subcommittee of the Joint Committee on Vaccination and Immunisation which provides advice to the UK government.
Wei Shen Lim's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report (2020) (4350)
- Dexamethasone in hospitalized patients with Covid19 (2021) (4096)
- Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study (2003) (2623)
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. (2020) (1694)
- BTS guidelines for the management of community acquired pneumonia in adults: update 2009 (2009) (1250)
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (1083)
- Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19 (2020) (1040)
- Co-infections in people with COVID-19: a systematic review and meta-analysis (2020) (1014)
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis (2014) (927)
- Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines (2001) (541)
- Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2020) (516)
- Mapping the human genetic architecture of COVID-19 (2021) (455)
- BTS Guidelines for the Management of Community Acquired Pneumonia in Adults (2001) (437)
- Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial (2021) (351)
- Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (316)
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial (2021) (282)
- Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009) (2010) (261)
- Corticosteroids as adjunctive therapy in the treatment of influenza. (2019) (241)
- Severity prediction rules in community acquired pneumonia: a validation study (2000) (224)
- Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (201)
- Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations (2011) (191)
- Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol (2021) (165)
- Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (162)
- A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. (2001) (151)
- Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study (2021) (136)
- Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021) (116)
- Corticosteroids as Adjunctive Therapy in the Treatment of Influenza: An Updated Cochrane Systematic Review and Meta-analysis. (2019) (115)
- Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia (2012) (114)
- Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations. (2002) (113)
- Primary care summary of the British Thoracic Society Guidelines for the management of community acquired pneumonia in adults: 2009 update. Endorsed by the Royal College of General Practitioners and the Primary Care Respiratory Society UK. (2010) (110)
- Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia (2015) (108)
- Pneumonia: update on diagnosis and management (2006) (107)
- Corticosteroids as adjunctive therapy in the treatment of influenza. (2016) (107)
- Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study (2021) (98)
- Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK (2021) (94)
- Cigarette smoking and the occurrence of Influenza - Systematic Review. (2019) (93)
- Tuberculosis and treatment with infliximab. (2002) (88)
- Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial. (2011) (86)
- COVID-19: a complex multisystem disorder (2020) (85)
- Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis (2022) (80)
- Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009–2010 in the UK (2012) (79)
- Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study (2021) (77)
- Defining prognostic factors in the elderly with community acquired pneumonia: a case controlled study of patients aged > or = 75 yrs. (2001) (72)
- Effect of corticosteroid therapy on influenza-related mortality: a systematic review and meta-analysis. (2015) (69)
- Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe (2017) (69)
- Pneumonia and pregnancy (2001) (64)
- Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013–18 (2019) (64)
- Co-infection in critically ill patients with COVID-19: an observational cohort study from England (2020) (64)
- CURB-65 pneumonia severity assessment adapted for electronic decision support. (2011) (63)
- Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic (2007) (61)
- Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 (2020) (60)
- Effect of tobacco smoking on the risk of developing community acquired pneumonia: A systematic review and meta-analysis (2019) (58)
- Pre-Admission Statin Use and In-Hospital Severity of 2009 Pandemic Influenza A(H1N1) Disease (2011) (57)
- Nosocomial Pandemic (H1N1) 2009, United Kingdom, 2009–2010 (2011) (57)
- Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09‐related pneumonia: an individual participant data meta‐analysis (2015) (57)
- Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK (2021) (56)
- Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial. (2019) (55)
- British Thoracic Society adult community acquired pneumonia audit 2009/10 (2011) (50)
- COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study (2021) (49)
- Corticosteroids as Adjunctive Therapy in the Treatment of Influenza: An Updated Cochrane Systematic Review and Meta-analysis. (2020) (46)
- Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults (2011) (43)
- Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study (2021) (42)
- Single versus combination antibiotic therapy in adults hospitalised with community acquired pneumonia (2012) (40)
- What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol (2020) (39)
- Pneumococcal serotypes in adult non-invasive and invasive pneumonia in relation to child contact and child vaccination status (2013) (38)
- Treatment of Community-Acquired Lower Respiratory Tract Infections during Pregnancy (2012) (35)
- The UK's pandemic influenza research portfolio: a model for future research on emerging infections. (2018) (34)
- Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings. (2010) (33)
- British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together (2015) (32)
- The effects of ethnicity on disease patterns in 472 Orientals with systemic lupus erythematosus. (1998) (31)
- The environmental deposition of influenza virus from patients infected with influenza A(H1N1)pdm09: Implications for infection prevention and control. (2016) (31)
- British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together (2015) (30)
- Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study (2020) (30)
- Mortality reduction in adult community-acquired pneumonia in the UK (2009–2014): results from the British Thoracic Society audit programme (2016) (30)
- Differences between asthmatics and nonasthmatics hospitalised with influenza A infection (2012) (30)
- What is the role of pulse oximetry in the assessment of patients with community-acquired pneumonia in primary care? (2010) (28)
- Immunogenicity and safety of a two-dose schedule of whole-virion and AS03(A)-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial (2011) (28)
- Time to first antibiotic and mortality in adults hospitalised with community-acquired pneumonia: a matched-propensity analysis (2015) (26)
- Ethical planning for an influenza pandemic. (2008) (26)
- British Thoracic Society community-acquired pneumonia care bundle: results of a national implementation project (2015) (24)
- Bird flu and pandemic flu (2005) (24)
- Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation. (2015) (23)
- The UK hibernated pandemic influenza research portfolio: triggered for COVID-19 (2020) (20)
- Adults miscoded and misdiagnosed as having pneumonia: results from the British Thoracic Society pneumonia audit (2017) (20)
- The Comparative Clinical Course of Pregnant and Non-Pregnant Women Hospitalised with Influenza A(H1N1)pdm09 Infection (2012) (19)
- The Relevance of Pneumococcal Serotypes (2014) (18)
- Does early review by a respiratory physician lead to a shorter length of stay for patients with non-severe community-acquired pneumonia? (2009) (18)
- The value of open-source clinical science in pandemic response: lessons from ISARIC (2021) (17)
- Importance of severity of illness assessment in management of lower respiratory infections (2004) (17)
- Serotypes associated with the development of pneumococcal para-pneumonic effusion in adults (2012) (15)
- Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England (2021) (14)
- Development of an Extended-Specificity Multiplex Immunoassay for Detection of Streptococcus pneumoniae Serotype-Specific Antigen in Urine by Use of Human Monoclonal Antibodies (2017) (14)
- Community-acquired Legionnaires' Disease in Nottingham – too many cases? (2003) (13)
- Comparison of CATs, CURB-65 and PMEWS as Triage Tools in Pandemic Influenza Admissions to UK Hospitals: Case Control Analysis Using Retrospective Data (2012) (13)
- Maximising benefit, reducing inequalities and ensuring deliverability: Prioritisation of COVID-19 vaccination in the UK (2020) (12)
- Stridor in Crohn disease and the use of infliximab. (2006) (12)
- The impact of an early chest radiograph on outcome in patients hospitalised with community-acquired pneumonia. (2010) (12)
- Point of care testing of Influenza A/B and RSV in an adult respiratory assessment unit is associated with improvement in isolation practices and reduction in hospital length of stay (2020) (11)
- Effect of ethnicity on care pathway and outcomes in patients hospitalized with influenza A(H1N1)pdm09 in the UK (2014) (11)
- A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart. (2010) (11)
- Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2020) (11)
- Management in primary care (2010) (11)
- Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study (2022) (10)
- Patient-reported outcome measures in the recovery of adults hospitalised with community-acquired pneumonia: a systematic review (2019) (10)
- Pulmonary exacerbations in cystic fibrosis and bronchiectasis (2007) (10)
- COVID-19 vaccination programme: a central role for primary care. (2021) (9)
- Clinical features of adults with seven-valent-conjugated-vaccine-serotype pneumococcal pneumonia. (2013) (9)
- Pneumonia—Overview (2020) (8)
- Severity assessment in community-acquired pneumonia: moving on (2007) (7)
- Non-invasive pneumococcal pneumonia due to vaccine serotypes: A systematic review and meta-analysis (2021) (7)
- Admission via the emergency department in relation to mortality of adults hospitalised with community-acquired pneumonia: an analysis of the British Thoracic Society national community-acquired pneumonia audit (2014) (7)
- Pneumonia in the context of severe sepsis: a significant diagnostic problem (2008) (7)
- Local guidelines for management of adult community acquired pneumonia: a survey of UK hospitals (2009) (7)
- How Do General Practitioners Respond to Reports of Abnormal Chest X-rays? (1999) (7)
- From latent to active TB: are IGRAs of any use? (2016) (7)
- Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study (2022) (7)
- A novel method for collecting and detecting amoxycillin in urine: a tool for testing antibiotic compliance in the community. (2000) (6)
- Tubular aggregate myopathy presenting with acute type II respiratory failure and severe orthopnoea (2005) (6)
- Conducting a randomised trial during an influenza pandemic: an example of a trial set up and ‘hibernated’ ready to activate and recruit within 4 weeks (2015) (6)
- Hospital acquired pneumonia. (2001) (6)
- 13-Valent vaccine serotype pneumococcal community acquired pneumonia in adults in high clinical risk groups. (2018) (6)
- Propionibacterium acnes pleural empyema following medical thoracoscopy (2017) (6)
- Healthcare reconsultation in working-age adults following hospitalisation for community-acquired pneumonia (2018) (5)
- An Evaluation of Community Assessment Tools (CATs) in Predicting Use of Clinical Interventions and Severe Outcomes during the A(H1N1)pdm09 Pandemic (2013) (5)
- Diagnosis of community-acquired pneumonia in adults (2009) (5)
- Delays in the diagnosis and surgical treatment of lung cancer. (1997) (5)
- Preparing for the next flu pandemic (2007) (5)
- Corrigendum to 'Primary care summary of the British Thoracic Society Guidelines for the management of community acquired pneumonia in adults: 2009 update' (Prim Care Resp J 2010;19(1):21-27). (2010) (5)
- Viral lung infections and the potential for a human pandemic (2008) (4)
- Splenic macrophages as the source of bacteraemia during pneumococcal pneumonia (2021) (4)
- Corticosteroids as adjunctive therapy in the treatment of influenza. (2021) (4)
- Nitric oxide for the prevention and treatment of viral, bacterial, protozoal and fungal infections (2021) (4)
- Community acquired pneumonia. (2004) (3)
- Respiratory viral infections, their interactions with SARS-CoV-2 and implications for a winter resurgence of COVID-19 (2020) (3)
- Increased incidence of adult pneumococcal pneumonia during school holiday periods (2017) (3)
- Re-validation and update of an extended-specificity multiplex assay for detection of Streptococcus pneumoniae capsular serotype/serogroup-specific antigen and cell-wall polysaccharide in urine specimens (2020) (3)
- Influenza, pandemics and SARS (2013) (2)
- The feasibility and tolerability of using inspiratory muscle training with adults discharged from the hospital with community-acquired pneumonia. (2021) (2)
- ORML Acute Respiratory Infections (2012) (2)
- Impact of social deprivation on clinical outcomes of adults hospitalised with community-acquired pneumonia in England: a retrospective cohort study (2022) (2)
- Systematic Review on the Effect of Current Smoking on the Risk of Influenza (2018) (2)
- The COVID-19 pandemic has highlighted the need to invest in care home research infrastructure (2022) (2)
- Clinicians’ attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza (2018) (2)
- Improving readiness for recruitment through simulated trial activation: the Adjuvant Steroids in Adults with Pandemic influenza (ASAP) trial (2017) (2)
- Meta-analysis of Acute Coronary Syndrome in Patients with Community-Acquired Pneumonia (2020) (1)
- Higher dose corticosteroids in hospitalised COVID-19 patients with hypoxia but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial (2022) (1)
- Admission to hospital in the UK at a weekend does not influence the prognosis of adults with community-acquired pneumonia (2020) (1)
- Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial (2023) (1)
- Variation in clinical outcomes and process of care measures in community acquired pneumonia: a systematic review (2020) (1)
- Pandemic influenza--how would you and your hospital cope? (2007) (1)
- Effects of tobacco smoking on recurrent hospitalisation with pneumonia: a population-based cohort study (2021) (1)
- Identifying failure of empirical treatment for pneumonia: vigilance and common sense (2004) (1)
- Late-breaking abstract: Relationship of asthma to outcome in influenza A/H1N1 2009 infection: FLU-CIN cohort study (2011) (1)
- Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study (2022) (1)
- Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients (2022) (1)
- Randomised trials during a public health crisis, such as pandemic flu: a case study for a model of ‘off the shelf' ready-to-go trials (2013) (1)
- Incidence of Cardiac Complications after Hospitalisation for Community Acquired Pneumonia: A Large Population-based Cohort Study (2020) (1)
- Nosocomial pneumonia (2020) (0)
- Who is Funding What in the Fight Against Pneumonia? (2015) (0)
- The art of medicine: recognising influenza and pneumonia. (2011) (0)
- Characteristics of patients with serotype 5 pneumococcal pneumonia (2020) (0)
- Confusion between the management of community acquired pneumonia in hospital versus primary care: a case of friendly fire? (2017) (0)
- Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial. JAMA-Journal of the American Medical Association (2019) (0)
- Diagnosis of community‑acquired (2009) (0)
- Pneumonia in the normal host (2020) (0)
- CME General Internal Medicine for the Physician – I Recent trends in the epidemiology of suicidal behaviour (2008) (0)
- Nitric oxide for the prevention and treatment of viral, bacterial, protozoal and fungal infections. (2021) (0)
- Development of an Extended-Specificity Multiplex Immunoassay for Detection of Streptococcus pneumoniae Serotype-Specific Antigen in Urine by Use of Human Monoclonal Antibodies (2017) (0)
- The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection (2023) (0)
- Respiratory tract infections: uncommon pathogens and misleading presentations. (2011) (0)
- Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2022) (0)
- Wideband speech coding based on mixed excitation linear prediction(MELP) (2000) (0)
- ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19 (2022) (0)
- Pulmonary Infections in Pregnancy (2020) (0)
- Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2023) (0)
- Community acquired pneumonia guidelines for primary care – pragmatic management at the front line. (2018) (0)
- The effect of coding on community acquired pneumonia reported mortality (2016) (0)
- Acoustic beamforming analysis for wearable blind aid applications (2018) (0)
- managementupdate on diagnosis and (2008) (0)
- Authors' response (2011) (0)
- 'Drink plenty of fluids' in acute respiratory infections (2017) (0)
- Antibiotics in respiratory tract infections (2012) (0)
- Infection for the acute physician. (2009) (0)
- Authors' response (2011) (0)
- Authors' reply (2010) (0)
- Pneumonia in adults - Quality standard QS110 (2016) (0)
- Do school holidays affect adult pneumococcal community acquired pneumonia incidence (2016) (0)
- Diagnosis and management of lower respiratory tract infections (2014) (0)
- Reasons for optimism in respiratory infections. (2023) (0)
- Pneumococcal respiratory disease and vaccines (2012) (0)
- Follow-up questionnaire (2015) (0)
- Recovery in adults hospitalised with community-acquired pneumonia; a systematic review and meta-analysis (2018) (0)
- Incidence of cognitive impairment and dementia after hospitalisation for pneumonia: a UK population-based matched cohort study (2022) (0)
- Clinical features of patients with pneumococcal urinary antigen positivity, in a cohort of hospitalised community acquired pneumonia (2012) (0)
- Development of an extended specificity multiplex immunoassay for detection of serotype-specific antigen in urine using human monoclonal antibodies. (2017) (0)
- Pneumonia: Let's avoid confusion of secondary and primary care issues in pneumonia (2006) (0)
- Debate: Are CAP Severity Scoring Systems Worthwhile to the Clinician? - For (2008) (0)
- Primary care consultations after hospitalisation for pneumonia: a large population-based cohort study (2020) (0)
- Less common and tropical respiratory tract infections (2012) (0)
- Dietary nitrate supplementation for preventing and reducing the severity of winter infections, including COVID-19, in care homes (BEET-Winter): a randomised placebo-controlled feasibility trial (2022) (0)
- Meta-analysis on the Effect of Current Smoking on the Risk of Developing Community Acquired Pneumonia (2018) (0)
This paper list is powered by the following services:
Other Resources About Wei Shen Lim
What Schools Are Affiliated With Wei Shen Lim?
Wei Shen Lim is affiliated with the following schools:
